This study evaluates whether odevixibat is safe and effective compared to placebo in children with biliaryatresia who have recently undergone a Kasai procedure. This is a double-blind study, so the study doctors and the child/parent will not know whether the child is receiving odevixibat or…
The purpose of this study is to see how effective and safe the drug maralixibat is when compared to placebo in infants with biliaryatresia who have had Kasai surgery within 3 weeks before participation. This is a 26-week, multicenter, double-blind, placebo-controlled, randomized parallel-group…